At the time of writing, Agios Pharmaceuticals Inc [AGIO] stock is trading at $45.66, up 0.35%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The AGIO shares have gain 10.61% over the last week, with a monthly amount drifted -1.91%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
On September 27, 2024, downgrade downgraded it’s rating to Market Perform and revised its price target to $56 on the stock. Cantor Fitzgerald started tracking the stock assigning a Overweight rating. Piper Sandler initiated its recommendation with a Overweight and recommended $41 as its price target on February 03, 2023. Goldman upgraded its rating to Neutral for this stock on November 17, 2022, and upped its price target to $32. In a note dated July 27, 2022, SVB Leerink upgraded an Outperform rating on this stock but restated the target price of $33.
For the past year, the stock price of Agios Pharmaceuticals Inc fluctuated between $19.80 and $53.28. Currently, Wall Street analysts expect the stock to reach $48.71 within the next 12 months. Agios Pharmaceuticals Inc [NASDAQ: AGIO] shares were valued at $45.66 at the most recent close of the market. An investor can expect a potential return of 6.68% based on the average AGIO price forecast.
Analyzing the AGIO fundamentals
According to Agios Pharmaceuticals Inc [NASDAQ:AGIO], the company’s sales were 31.31M for trailing twelve months, which represents an 28.35% jump. Gross Profit Margin for this corporation currently stands at 0.75% with Operating Profit Margin at -12.94%, Pretax Profit Margin comes in at -11.66%, and Net Profit Margin reading is -11.66%. To continue investigating profitability, this company’s Return on Assets is posted at -0.47, Equity is -0.47 and Total Capital is -0.57. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.1.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 45.22 points at the first support level, and at 44.77 for the second support level. However, for the 1st resistance point, the stock is sitting at 46.08, and for the 2nd resistance point, it is at 46.49.
Ratios To Look Out For
It is important to note that Agios Pharmaceuticals Inc [NASDAQ:AGIO] has a current ratio of 10.09. As well, the Quick Ratio is 9.71, while the Cash Ratio is 1.35. Considering the valuation of this stock, the price to sales ratio is 82.96, the price to book ratio is 3.93.
Transactions by insiders
Recent insider trading involved Jones Cecilia, Chief Financial Officer, that happened on Sep 26 ’24 when 2542.0 shares were sold. Chief Executive Officer, Goff Brian completed a deal on Aug 08 ’24 to sell 11091.0 shares. Meanwhile, Officer Goff Brian bought 11091.0 shares on Aug 08 ’24.
